Clinical Research Focus. 56th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of July 2026. Read more
Cromos Pharma Regulatory Radar | 2026 Mid-Year Update Clinical trial regulation is moving quickly in 2026. Since January, the FDA has opened the door wider to Bayesian trial designs, started testing real time data sharing, updated its approach to master protocols and oncology eligibility criteria, and proposed new ways to accelerate early clinical development. In Europe, attention is shifting from implementing the Clinical Read more
Big Pharma is betting billions on vaccines. Washington is making that bet harder to win. Vaccines are going through a strange moment. On one side, the science is moving faster than it has in years, and pharma is putting real money behind it. On the other side, the regulatory ground in the US, the world’s largest vaccine market, keeps shifting under sponsors’ feet. For anyone running clinical development, that combination Read more
The Next GLP-1 Moment? Why Big Pharma Is Investing in Depression Only a few years ago, psychedelic medicine sat on the fringes of pharmaceutical research. Today, it has become one of the industry’s fastest-growing investment areas. In July, Eli Lilly announced a $2.8 billion acquisition of Atai Beckley, gaining access to BPL-003, an intranasal 5-MeO-DMT therapy for treatment-resistant depression. It wasn’t an isolated move. Johnson & Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us